Cyanotech Corp CYAN
We take great care to ensure that the data presented and summarized in this overview for CYANOTECH CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in CYAN
Top Purchases
Top Sells
About CYAN
Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company's products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant to enhance skin, and to support eye, joint and immune health, as well as used as a human dietary supplement and dietary ingredient; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement, which is used for extra energy, strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. It also provides contract extraction services. The company sells its products through distributors, retailers, and online channels; direct to consumers; and in bulk form to manufacturers, formulators, and distributors in the health foods, nutraceuticals, and dietary supplement markets. Cyanotech Corporation was incorporated in 1983 and is headquartered in Kailua-Kona, Hawaii.
Insider Transactions at CYAN
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 01
2024
|
Michael A / Davis Director |
BUY
Grant, award, or other acquisition
|
Indirect |
13,158
+0.88%
|
$0
$0.76 P/Share
|
|
Oct 01
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.34%
|
$0
$0.76 P/Share
|
|
Sep 30
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.34%
|
$0
$0.76 P/Share
|
|
Sep 27
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.34%
|
$0
$0.77 P/Share
|
|
Sep 26
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.34%
|
$0
$0.77 P/Share
|
|
Sep 25
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.34%
|
$0
$0.77 P/Share
|
|
Sep 24
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.35%
|
$0
$0.73 P/Share
|
|
Sep 23
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.35%
|
$0
$0.77 P/Share
|
|
Sep 20
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.35%
|
$0
$0.77 P/Share
|
|
Sep 19
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.35%
|
$0
$0.74 P/Share
|
|
Sep 18
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.35%
|
$0
$0.78 P/Share
|
|
Sep 17
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.18%
|
$0
$0.73 P/Share
|
|
Sep 16
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.35%
|
$0
$0.82 P/Share
|
|
Sep 13
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.35%
|
$0
$0.82 P/Share
|
|
Sep 12
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.36%
|
$0
$0.83 P/Share
|
|
Sep 11
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.36%
|
$0
$0.83 P/Share
|
|
Sep 10
2024
|
Michael A / Davis Director |
BUY
Grant, award, or other acquisition
|
Indirect |
66,667
+4.58%
|
$0
$0.75 P/Share
|
|
Sep 10
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.38%
|
$0
$0.83 P/Share
|
|
Sep 09
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.38%
|
$0
$0.84 P/Share
|
|
Sep 06
2024
|
Michael A / Davis Director |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.38%
|
$0
$0.84 P/Share
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 37.6K shares |
|---|---|
| Open market or private purchase | 337K shares |
| Grant, award, or other acquisition | 196K shares |
| Payment of exercise price or tax liability | 14.3K shares |
|---|